Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Shibo Zhenmei Technology is a biotechnology firm headquartered in Wuhan, China, dedicated to the field of regenerative medicine and medical aesthetics. The company focuses on the development of high-performance skin repair products, utilizing bioactive proteins and advanced formulation technologies to treat dermatological conditions and signs of aging. Their portfolio includes a range of medical-grade dressings, functional cosmetics, and Class II and III medical devices designed for post-procedure recovery and general skin health. By bridging the gap between clinical research and aesthetic application, Shibo Zhenmei has established itself as a key player in the regional Optics Valley biotech cluster. The company maintains integrated R&D and manufacturing capabilities to support its growing line of regenerative products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Shibo Zhenmei Technology.